SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Cho I Lee, So Young Kwon, Jeong Han Kim, Won Hyeok Choe, Chang Hong Lee, Eileen L. Yoon, Jong Eun Yeon, Kwan Soo Byun, Yun Soo Kim, Ju Hyun Kim, Efficacy and Safety of Tenofovir-Based Rescue Therapy for Chronic Hepatitis B Patients with Previous Nucleo(s/t)ide Treatment Failure, Gut and Liver, 2014, 8, 1, 64

    CrossRef

  2. 2
    Massimiliano Paganelli, Kai Dallmeier, Omar Nyabi, Isabelle Scheers, Benoît Kabamba, Johan Neyts, Patrick Goubau, Mustapha Najimi, Etienne M. Sokal, Differentiated umbilical cord matrix stem cells as a new in vitro model to study early events during hepatitis B virus infection, Hepatology, 2013, 57, 1
  3. 3
    Wai-Kay Seto, Man-Fung Yuen, James Fung, Ching-Lung Lai, Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection, Hepatology International, 2013, 7, 2, 327

    CrossRef

  4. 4
    Tsunamasa Watanabe, Fuminaka Sugauchi, Shigeru Kusumoto, Noboru Shinkai, Etsuko Iio, Kentarou Matsuura, Atsunori Kusakabe, Tomokatsu Miyaki, Syunsuke Nojiri, Yasuhito Tanaka, A case report of successful therapy with tenofovir for a multi-drug resistant chronic hepatitis B patient complicated with malignant lymphoma, Kanzo, 2012, 53, 1, 35

    CrossRef

  5. 5
    Olivier Lada, Anne Gervais, Michel Branger, Gilles Peytavin, Benedicte Roquebert, Gilles Collin, Gil Fraqueiro, Rami Moucari, Gwen Hamet, Michelle Martinot-Peignoux, Sophie Matheron, Patrick Marcellin, Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G, Liver International, 2012, 32, 1
  6. 6
    Sang-Hoon Ahn, Young-Oh Kweon, Seung-Woon Paik, Joo-Hyun Sohn, Kwan-Sik Lee, Dong Joon Kim, Teerha Piratvisuth, Man Fung Yuen, Anuchit Chutaputti, You-Chen Chao, Aldo Trylesinski, Claudio Avila, Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B, Hepatology International, 2012, 6, 4, 696

    CrossRef

  7. 7
    Yuk-Fai Lam, Man-Fung Yuen, Wai-Kay Seto, Ching-Lung Lai, Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety, Current Hepatitis Reports, 2011, 10, 4, 235

    CrossRef

  8. 8
    Lucila Cassino, Silvina Benetti, Fabian Fay, Hugo Tanno, Jorge Quarleri, Unsuccessful therapy with adefovir and entecavir-tenofovir in a patient with chronic hepatitis B infection with previous resistance to lamivudine: a fourteen-year evolution of hepatitis B virus mutations, BMC Infectious Diseases, 2011, 11, 1, 178

    CrossRef

  9. 9
    Mashu Aizawa, Akihito Tsubota, Kiyotaka Fujise, Tetsuro Kato, Mitsuo Sakamoto, Toshifumi Ohkusa, Hisao Tajiri, Highly active antiretroviral therapy improved persistent lamivudine-resistant viremia in acute hepatitis B virus genotype Ae infection with coinfection of human immunodeficiency virus, Hepatology Research, 2010, 40, 2
  10. 10
    T. Asselah, O. Lada, P. Marcellin, Résultats des essais thérapeutiques dans l’hépatite chronique B, Antibiotiques, 2010, 12, 1, 42

    CrossRef

  11. 11
    Erik De Clercq, Another ten stories in antiviral drug discovery (part C): “Old” and “new” antivirals, strategies, and perspectives, Medicinal Research Reviews, 2009, 29, 4
  12. 12
    Florian van Bömmel, Thomas Berg, Role of tenofovir in the treatment of chronic HBV infection, Future Virology, 2008, 3, 3, 207

    CrossRef

  13. 13
    Wilhelmus F. Leemans, Hubert G. Niesters, Annemiek A. van der Eijk, Harry L. Janssen, Solko W. Schalm, Robert A. de Man, Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir, European Journal of Gastroenterology & Hepatology, 2008, 20, 8, 773

    CrossRef

  14. 14
    W. F. Leemans, H. L. A. Janssen, H. G. M. Niesters, R. A. De Man, Switching patients with lamivudine resistant chronic hepatitis B virus from tenofovir to adefovir results in less potent HBV-DNA suppression, Journal of Viral Hepatitis, 2008, 15, 2
  15. 15
    Jessica Tan, Bulent Degertekin, Stephen N. Wong, Munira Husain, Kelly Oberhelman, Anna S.F. Lok, Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations, Journal of Hepatology, 2008, 48, 3, 391

    CrossRef

  16. 16
    T. Asselah, O. Lada, N. Boyer, M. Martinot, P. Marcellin, Traitement de l’hépatite chronique B, Gastroentérologie Clinique et Biologique, 2008, 32, 8-9, 749

    CrossRef

  17. 17
    Peter G. Stock, Michelle E. Roland, Evolving Clinical Strategies for Transplantation in the HIV-Positive Recipient, Transplantation, 2007, 84, 5, 563

    CrossRef

  18. 18
    Yves Benhamou, Hepatitis B in the HIV-Coinfected Patient, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2007, 45, Supplement 2, S57

    CrossRef

  19. 19
    Rafik Samuel, Robert Bettiker, Byungse Suh, Antiretroviral therapy 2006: Pharmacology, applications, and special situations, Archives of Pharmacal Research, 2006, 29, 6, 431

    CrossRef

  20. 20
    Marc G. Ghany, Edward C. Doo, Assessment and Management of Chronic Hepatitis B, Infectious Disease Clinics of North America, 2006, 20, 1, 63

    CrossRef

  21. 21
    Brent E Korba, Phillip A Furman, Michael J Otto, Clevudine: a potent inhibitor of hepatitis B virusin vitroandin vivo, Expert Review of Anti-infective Therapy, 2006, 4, 4, 549

    CrossRef

  22. 22
    Stephanie A. Santos, Alison J. Uriel, James S. Park, Jennifer Lucas, Damaris Carriero, David Jaffe, Douglas T. Dieterich, Effect of switching to tenofovir with emtricitabine in patients with chronic hepatitis B failing to respond to an adefovir-containing regimen, European Journal of Gastroenterology & Hepatology, 2006, 18, 12, 1247

    CrossRef

  23. 23
    Tim Shaw, Angeline Bartholomeusz, Stephen Locarnini, HBV drug resistance: Mechanisms, detection and interpretation, Journal of Hepatology, 2006, 44, 3, 593

    CrossRef

  24. 24
    Raymond F. Schinazi, Brenda I. Hernandez-Santiago, Selwyn J. Hurwitz, Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses, Antiviral Research, 2006, 71, 2-3, 322

    CrossRef

  25. 25
    Marion G. Peters, Janet Andersen, Patrick Lynch, Tun Liu, Beverly Alston-Smith, Carol L. Brosgart, Jeffrey M. Jacobson, Victoria A. Johnson, Richard B. Pollard, James F. Rooney, Kenneth E. Sherman, Susan Swindells, Bruce Polsky, Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127, Hepatology, 2006, 44, 5
  26. 26
    Man-Fung Yuen, Ching-Lung Lai, Recommendations and potential future options in the treatment of hepatitis B, Expert Opinion on Pharmacotherapy, 2006, 7, 16, 2225

    CrossRef

  27. 27
    Yves Benhamou, Treatment algorithm for chronic hepatitis B in HIV-infected patients, Journal of Hepatology, 2006, 44, S90

    CrossRef

  28. 28
    Rosa Zampino, Aldo Marrone, Luigi Elio Adinolfi, Giuseppe Ruggiero, Treatment of chronic hepatitis B: efficacy of current drugs and prospects for the future, Expert Review of Clinical Immunology, 2006, 2, 6, 915

    CrossRef

  29. 29
    Oliver Schildgen, Hueseyin Sirma, Anneke Funk, Cynthia Olotu, Ulrike C. Wend, Heinz Hartmann, Martin Helm, Jürgen K. Rockstroh, Wulf R. Willems, Hans Will, Wolfram H. Gerlich, Variant of Hepatitis B Virus with Primary Resistance to Adefovir, New England Journal of Medicine, 2006, 354, 17, 1807

    CrossRef

  30. 30
    T.E.M.S. de Vries-Sluijs, A.A. van der Eijk, B.E. Hansen, A.D.M.E. Osterhaus, R.A. de Man, M.E. van der Ende, Wild type and YMDD variant of hepatitis B virus: No difference in viral kinetics on lamivudine/tenofovir therapy in HIV–HBV co-infected patients, Journal of Clinical Virology, 2006, 36, 1, 60

    CrossRef

  31. 31
    Yves Benhamou, HIV-1/hepatitis B coinfection, Expert Review of Anti-infective Therapy, 2005, 3, 2, 229

    CrossRef

  32. 32
    Karine Lacombe, Joël Gozlan, Pierre-Yves Boelle, Lawrence Serfaty, Fabien Zoulim, Alain-Jacques Valleron, Pierre-Marie Girard, Long-term hepatitis B virus dynamics in HIV–hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate, AIDS, 2005, 19, 9, 907

    CrossRef

  33. 33
    Florian van Bömmel, Thomas Berg, Reactivation of viral replication after replacement of tenofovir by adefovir, Hepatology, 2005, 42, 1
  34. 34
    David Durantel, Marie-Noelle Brunelle, Edwige Gros, Sandra Carrouée-Durantel, Christian Pichoud, Stephanie Villet, Christian Trepo, Fabien Zoulim, Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing, Journal of Clinical Virology, 2005, 34, S34

    CrossRef

  35. 35
    Teresa C. Taltavull, Nadia Chahri, Blanca Verdura, Joan Gornals, Carmen Lopez, Aurora Casanova, Concha Cañas, Juan Figueras, Luis A. Casais, Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results, Transplant International, 2005, 18, 7
  36. 36
    Marie-Noëlle Brunelle, Anne-Carole Jacquard, Christian Pichoud, David Durantel, Sandra Carrouée-Durantel, Jean-Pierre Villeneuve, Christian Trépo, Fabien Zoulim, Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir, Hepatology, 2005, 41, 6
  37. 37
    Brian P. Kearney, Srinivasan Ramanathan, Andrew K. Cheng, Ramin Ebrahimi, Jaymin Shah, Systemic and Renal Pharmacokinetics of Adefovir and Tenofovir Upon Coadministration, The Journal of Clinical Pharmacology, 2005, 45, 8
  38. 38
    Patrick Yachimski, Raymond T. Chung, Update on hepatitis B and C coinfection in HIV, Current Infectious Disease Reports, 2005, 7, 4, 299

    CrossRef

  39. 39
    A. A. Eijk, B. E. Hansen, H. G. M. Niesters, H. L. A. Janssen, M. Ende, S. W. Schalm, R. A. Man, Viral dynamics during tenofovir therapy in patients infected with lamivudine-resistant hepatitis B virus mutants, Journal of Viral Hepatitis, 2005, 12, 4
  40. 40
    Y. Benhamou, Antiretroviral Therapy and HIV/Hepatitis B Virus Coinfection, Clinical Infectious Diseases, 2004, 38, Supplement 2, S98

    CrossRef

  41. 41
    David J Quan, Marion G Peters, Antiviral therapy: nucleotide and nucleoside analogs, Clinics in Liver Disease, 2004, 8, 2, 371

    CrossRef

  42. 42
    Edward P. Armstrong, Scott L. Charland, Burden of illness of hepatitis C from a managed care organization perspective, Current Medical Research and Opinion, 2004, 20, 5, 671

    CrossRef

  43. 43
    Nassim Kamar, Karine Sandres-Saune, David Ribes, Michel Duffaut, Jannick Selves, Dominique Durand, Jacques Izopet, Lionel Rostaing, Effects of long-term lamivudine therapy in renal-transplant patients, Journal of Clinical Virology, 2004, 31, 4, 298

    CrossRef

  44. 44
    Don Ganem, Alfred M. Prince, Hepatitis B Virus Infection — Natural History and Clinical Consequences, New England Journal of Medicine, 2004, 350, 11, 1118

    CrossRef

  45. 45
    Marc G. Ghany, Edward C. Doo, Management of chronic hepatitis B, Gastroenterology Clinics of North America, 2004, 33, 3, 563

    CrossRef

  46. 46
    Chee-kin Hui, Hai-ying Zhang, George K.K. Lau, Management of chronic hepatitis B in treatment-experienced patients, Gastroenterology Clinics of North America, 2004, 33, 3, 601

    CrossRef

  47. 47
    F. Bani-Sadr, P. Palmer, C. Scieux, J. M. Molina, Ninety-Six–Week Efficacy of Combination Therapy with Lamivudine and Tenofovir in Patients Coinfected with HIV-1 and Wild-Type Hepatitis B Virus, Clinical Infectious Diseases, 2004, 39, 7, 1062

    CrossRef

  48. 48
    Damian J McColl, Nicolas A Margot, Michael Wulfsohn, Dion F Coakley, Andrew K Cheng, Michael D Miller, Patterns of Resistance Emerging in HIV-1 From Antiretroviral-Experienced Patients Undergoing Intensification Therapy With Tenofovir Disoproxil Fumarate, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2004, 37, 3, 1340

    CrossRef

  49. 49
    H. M. Younger, A. J. Bathgate, P. C. Hayes, Review article: nucleoside analogues for the treatment of chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2004, 20, 11-12
  50. 50
    Alexander Kuo, Jules L Dienstag, Raymond T Chung, Tenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B, Clinical Gastroenterology and Hepatology, 2004, 2, 3, 266

    CrossRef

  51. 51
    Christian Braegger, To Treat or Not to Treat:That Is the Question, Journal of Pediatric Gastroenterology and Nutrition, 2004, 39, 1, 103

    CrossRef

  52. 52
    Yves Benhamou, Luminita Bonyhay, Treatment of hepatitis B virus infection in patients coinfected with HIV, Gastroenterology Clinics of North America, 2004, 33, 3, 617

    CrossRef

  53. 53
    Claire Thomas, Mark Nelson, Justin Stebbing, HIV and Hepatitis B: A Review, AIDS Patient Care and STDs, 2003, 17, 12, 623

    CrossRef

  54. 54
    Michelle E. Roland, Deborah Adey, Laurie L. Carlson, Norah A. Terrault, Kidney and Liver Transplantation in HIV-Infected Patients: Case Presentations and Review, AIDS Patient Care and STDs, 2003, 17, 10, 501

    CrossRef

  55. 55
    Michelle E. Roland, Peter G. Stock, Review of solid-organ transplantation in HIV-infected patients, Transplantation, 2003, 75, 4, 425

    CrossRef

  56. 56
    Yves Benhamou, Roland Tubiana, Vincent Thibault, Tenofovir Disoproxil Fumarate in Patients with HIV and Lamivudine-Resistant Hepatitis B Virus, New England Journal of Medicine, 2003, 348, 2, 177

    CrossRef

  57. 57
    M. Nunez, M. Puoti, N. Camino, V. Soriano, Treatment of Chronic Hepatitis B in the Human Immunodeficiency Virus-Infected Patient: Present and Future, Clinical Infectious Diseases, 2003, 37, 12, 1678

    CrossRef

  58. 58
    Yves Benhamou, Thierry Poynard, Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus, Journal of Hepatology, 2003, 39, 194

    CrossRef

  59. 59
    Ching Lung Lai, Vlad Ratziu, Man-Fung Yuen, Thierry Poynard, Viral hepatitis B, The Lancet, 2003, 362, 9401, 2089

    CrossRef

  60. 60
    Giuseppe Gumina, Yongseok Choi, Chung K. Chu, Antiviral Nucleosides, 2003,

    CrossRef

  61. 61
    Angeline Bartholomeusz, Phillip Furman, Stephen Locarnini, Frontiers in Viral Hepatitis, 2003,

    CrossRef

  62. 62
    George R. Painter, Laurence T. Rimsky, Phillip A. Furman, Dennis C. Liotta, Raymond F. Schinazi, Joseph B. Quinn, Frontiers in Viral Hepatitis, 2003,

    CrossRef

  63. 63
    Marina Núñez, Mayte Pérez-Olmeda, Beatriz Díaz, Pilar Ríos, Juan González-Lahoz, Vincent Soriano, Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine, AIDS, 2002, 16, 17, 2352

    CrossRef

  64. 64
    Justin G Julander, Robert W Sidwell, John D Morrey, Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus, Antiviral Research, 2002, 55, 1, 27

    CrossRef

  65. 65
    ROBERT YM CHEN, PAUL V DESMOND, STEPHEN A LOCARNINI, Emerging therapies of hepatitis B and C, Journal of Gastroenterology and Hepatology, 2002, 17,
  66. 66
    Horatio B. Fung, Elizabeth A. Stone, Frank J. Piacenti, Tenofovir disoproxil fumarate: A nucleotide reverse transcriptase inhibitor for the treatment of HIV infection, Clinical Therapeutics, 2002, 24, 10, 1515

    CrossRef

  67. 67
    E. De Clercq, G. Andrei, R. Snoeck, L. De Bolle, L. Naesens, B. Degrève, J. Balzarini, Y. Zhang, D. Schols, P. Leyssen, C. Ying, J. Neyts, ACYCLIC/CARBOCYCLIC GUANOSINE ANALOGUES AS ANTI-HERPESVIRUS AGENTS, Nucleosides, Nucleotides and Nucleic Acids, 2001, 20, 4-7, 271

    CrossRef

  68. 68
    Johan Neyts, Lieve Naesens, Chunxiao Ying, Leen De Bolle, Erik De Clercq, Anti-herpesvirus activity of (1′S,2′R)-9-[[1′,2′-bis(hydroxymethyl)-cycloprop-1′-yl]methyl]guanine (A-5021) in vitro and in vivo, Antiviral Research, 2001, 49, 2, 115

    CrossRef

  69. 69
    Karl P Fischer, Klaus S Gutfreund, D.Lorne Tyrrell, Lamivudine resistance in hepatitis B: mechanisms and clinical implications, Drug Resistance Updates, 2001, 4, 2, 118

    CrossRef

  70. 70
    C Ying, E De Clercq, J Neyts, Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus, Antiviral Research, 2000, 48, 2, 117

    CrossRef

  71. 71
    Ramachandra S. Hosmane, Antiviral Agents, Kirk-Othmer Encyclopedia of Chemical Technology,
  72. 72
    Ashoke Sharon, Ashok K. Jha, Chung K. Chu, Clevudine, to Treat Hepatitis B Viral Infection,
  73. 73
    Erik De Clercq, Discovery and Development of Tenofovir Disoproxil Fumarate,
  74. 74
    Veerendra Sandur, George Therapondos, Infections in the Liver,